Reimbursement for Prostate MRI Analysis
Understanding CPT Codes
for Prostate MRI Analysis
Prostate MRI plays a critical role in detecting and evaluating prostate cancer, and the availability of Category I CPT codes ensures that providers can seek reimbursement for these essential imaging services.
By utilizing these codes, healthcare providers can help drive broader adoption and support reimbursement efforts for advanced prostate MRI analysis, ensuring that advanced imaging tools remain accessible for enhancing patient care and clinical decision-making.
OnQ Prostate: Next-Level Prostate Imaging
OnQ Prostate is an advanced solution designed to enhance prostate MRI interpretation by providing quantitative imaging analysis that improves lesion conspicuity, supporting more accurate radiology assessment clinical decision-making across the prostate cancer care pathway.
Key Features
Restriction Spectrum Imaging (RSI)
A patented diffusion MRI method exclusive to OnQ Prostate, offering enhanced lesion conspicuity.
Enhanced Confidence in Assessment
Helps radiologists assess indeterminate lesions, reducing inter-reader variability.
Seamless PACS Integration
Works within existing imaging workflows for efficient reporting and analysis
Improved Physician Communication
Supports shared decision-making between radiologists, urologists, and oncologists.
How does this impact your billing practice?
As advanced imaging gains momentum in prostate cancer diagnostics, ensuring the correct use of CPT codes is essential for securing reimbursement and driving further clinical adoption.
For guidance on implementing OnQ Prostate with CPT codes, or for any reimbursement-related questions, contact us at reimbursementsupport@cortechs.ai.
Let’s work together to advance prostate MRI analysis and expand patient access to cutting-edge prostate cancer imaging.
Have a question?
For any questions on how to implement these codes, or for guidance on their usage, reach out to a team member
